Biobanking of Rett Syndrome and Related Disorders

CompletedOBSERVATIONAL
Enrollment

752

Participants

Timeline

Start Date

September 1, 2017

Primary Completion Date

July 31, 2021

Study Completion Date

July 31, 2021

Conditions
Rett SyndromeMECP2 DuplicationCDKL5FOXG1 Disorders
Trial Locations (12)

29646

Greenwood Genetic Center, Greenwood

35294

University of Alabama at Birmingham, Birmingham

37212

Vanderbilt University, Nashville

55101

Gillette Children's Specialty Healthcare, Minneapolis

60612

Rush University Medical Center, Chicago

77030

Baylor College of Medicine, Houston

92123

University of California San Diego, San Diego

94709

UCSF Benioff Children's Hospital Oakland, Oakland

80045-2571

University of Colorado Denver, Denver

02115

Children's Hospital Boston, Boston

63110-1093

Washington University School of Medicine and St. Louis Children's Hospital, St Louis

19104-4318

Children's Hospital of Philadelphia, Philadelphia

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Center for Advancing Translational Sciences (NCATS)

NIH

collaborator

Office of Rare Diseases (ORD)

NIH

collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

lead

University of Alabama at Birmingham

OTHER

NCT02705677 - Biobanking of Rett Syndrome and Related Disorders | Biotech Hunter | Biotech Hunter